Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Notable Labs grants Cures Within Reach commercial rights to pediatric leukemia compound

Chris Lieu
January 25, 2019 6:28 PM UTC

Notable Labs Inc. (Foster City, Calif.) granted non-profit Cures Within Reach (Chicago, Ill.) commercial rights to ND-1000 for pediatric leukemia.

The company said the first clinical trial of ND-1000 is slated to start in mid-2019 at the University of Kansas Medical Center in pediatric patients with chronic lymphocytic leukemia (CLL). ND-1000 is a combination of an undisclosed generic drug and an undisclosed natural product...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Notable Labs Inc.